Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases
United European Gastroenterology Journal | Mar 29, 2019
Anlotinib vs sunitinib as first-line treatment for metastatic renal cell carcinoma: A randomized phase II clinical trial
The Oncologist | Mar 28, 2019
CA125 over-release behavior following a 75-g oral glucose test as a predictive biomarker of multidrug resistance in patients with ovarian cancer
International Journal of Cancer | Mar 28, 2019
Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial
International Journal of Cancer | Mar 28, 2019
Effect of NSAIDs on bone healing rates: A meta-analysis
Journal of the American Academy of Orthopedic Surgeons | Mar 28, 2019
Association of lowering low-density lipoprotein cholesterol with contemporary lipid-lowering therapies and risk of diabetes mellitus: A systematic review and meta-analysis
Journal of the American Heart Association | Mar 28, 2019